Bicara Therapeutics Inc. Common Stock (BCAX) Research Hub

Bicara Therapeutics Inc. Common Stock (BCAX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 16.89 USD (-1.05%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.06, market cap 1.51B. This hub links to the full technical, earnings and options research available for BCAX.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close16.89 USD (-1.05%)
52-week range15.85 USD – 30.99 USD
Trend regimeRange
14-day RSI53 (Neutral)
Trailing P/E-10.06
Market cap1.51B
Dividend yield0.00%
Next earnings2026-08-11

Available research for BCAX

Earnings

BCAX earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -10.06. Updated 2026-07-23.

Options: Covered Call

Covered Call on BCAX: how it works, illustrative setup around the real 16.89 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on BCAX: how it works, illustrative setup around the real 16.89 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on BCAX: how it works, illustrative setup around the real 16.89 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

BCAX technical analysis: range, last 16.89 USD, RSI 53, 52w range 15.85 USD–30.99 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is BCAX in?

Bicara Therapeutics Inc. Common Stock (BCAX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is BCAX in an uptrend or downtrend?

As of 2026-10-26, BCAX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is BCAX's trailing P/E ratio?

BCAX's trailing P/E is -10.06, with a market cap of 1.51B. See the earnings research page for full valuation detail.

When does BCAX next report earnings?

BCAX is next scheduled to report earnings on 2026-08-11.